DAIKIN INDUSTRI/ADR (OTCMKTS:DKILY) Reaches New 12-Month High at $14.47

Share on StockTwits

DAIKIN INDUSTRI/ADR (OTCMKTS:DKILY)’s stock price hit a new 52-week high during trading on Tuesday . The stock traded as high as $14.47 and last traded at $14.25, with a volume of 48811 shares. The stock had previously closed at $14.17.

Several brokerages have recently commented on DKILY. ValuEngine upgraded shares of DAIKIN INDUSTRI/ADR from a “sell” rating to a “hold” rating in a research report on Friday, November 1st. Zacks Investment Research cut shares of DAIKIN INDUSTRI/ADR from a “buy” rating to a “hold” rating in a research report on Tuesday, August 27th.

The firm’s 50 day moving average is $13.67 and its two-hundred day moving average is $12.97. The firm has a market cap of $41.53 billion, a P/E ratio of 24.15, a price-to-earnings-growth ratio of 2.32 and a beta of 0.78. The company has a current ratio of 1.75, a quick ratio of 1.19 and a debt-to-equity ratio of 0.26.

DAIKIN INDUSTRI/ADR Company Profile (OTCMKTS:DKILY)

Daikin Industries, Ltd. manufactures, distributes, and sells air-conditioning and refrigeration equipment, and chemical products. Its air-conditioning products include room air-conditioning systems, air purifiers, heat-pump hot-water-supply and room-heating systems, packaged air-conditioning systems, multiple air-conditioning systems for office buildings, air-conditioning systems for facilities and plants, absorption refrigerators, freezers, water chillers, turbo refrigerator equipment, air-handling units, air filters, industrial dust collectors, and marine-type container refrigeration systems.

Recommended Story: What is the Hang Seng index?  

Receive News & Ratings for DAIKIN INDUSTRI/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DAIKIN INDUSTRI/ADR and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Analysts Set $33.00 Target Price for SpringWorks Therapeutics
Analysts Set $33.00 Target Price for SpringWorks Therapeutics
Ardelyx Inc  Given Consensus Rating of “Hold” by Analysts
Ardelyx Inc Given Consensus Rating of “Hold” by Analysts
Western Midstream Partners LP  Receives $32.25 Consensus Price Target from Analysts
Western Midstream Partners LP Receives $32.25 Consensus Price Target from Analysts
SL Green Realty Corp  Receives $93.85 Average Price Target from Brokerages
SL Green Realty Corp Receives $93.85 Average Price Target from Brokerages
HC Wainwright Reaffirms Buy Rating for Y-mAbs Therapeutics
HC Wainwright Reaffirms Buy Rating for Y-mAbs Therapeutics
Analysts Set SS&C Technologies Holdings, Inc.  Price Target at $65.91
Analysts Set SS&C Technologies Holdings, Inc. Price Target at $65.91


© 2006-2019 Ticker Report